These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

47 related articles for article (PubMed ID: 6441130)

  • 1. [Stages in prevention of breast neoplasms. Organization of standard computerized operative programs: preliminary prospective study].
    Asteria CR; Bonera A; Di Giovanni M; Scheda RG
    Minerva Med; 1984 Dec; 75(47-48):2809-14. PubMed ID: 6441130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breast cancer screening policies in developing countries: a cost-effectiveness analysis for India.
    Okonkwo QL; Draisma G; der Kinderen A; Brown ML; de Koning HJ
    J Natl Cancer Inst; 2008 Sep; 100(18):1290-300. PubMed ID: 18780864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of the diagnostic methods on the therapeutic strategies.
    Greco M; Agresti R; Giovanazzi R
    Q J Nucl Med; 1998 Mar; 42(1):66-80. PubMed ID: 9646647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Economic and cost-effectiveness issues in breast cancer treatment.
    Hillner BE
    Semin Oncol; 1996 Feb; 23(1 Suppl 2):98-104. PubMed ID: 8614853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of screening for cancer in the Nordic countries on deaths, cost and quality of life up to the year 2017.
    Hristova L; Hakama M
    Acta Oncol; 1997; 36 Suppl 9():1-60. PubMed ID: 9143316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evolution of multiple disease screening in Keelung: a model for community involvement in health interventions?
    Wang PE; Wang TT; Chiu YH; Yen AM; Chen TH
    J Med Screen; 2006; 13 Suppl 1():S54-8. PubMed ID: 17227644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening for breast cancer and cost-effectiveness of thermal diagnostic techniques.
    Berger GS; Keith LG
    Prog Clin Biol Res; 1982; 107():839-49. PubMed ID: 6820147
    [No Abstract]   [Full Text] [Related]  

  • 8. The effect of service screening on breast cancer mortality rates.
    Cox B
    Eur J Cancer Prev; 2008 Aug; 17(4):306-11. PubMed ID: 18562953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breast cancer screening, outside the population-screening program, of women from breast cancer families without proven BRCA1/BRCA2 mutations: a simulation study.
    Jacobi CE; Nagelkerke NJ; van Houwelingen JH; de Bock GH
    Cancer Epidemiol Biomarkers Prev; 2006 Mar; 15(3):429-36. PubMed ID: 16537697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Economic approach to breast cancer screening in Belgium].
    Grivegnée AR; Autier P
    Rev Med Brux; 2001 Sep; 22(4):A277-81. PubMed ID: 11680188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Developing and testing a cost-assessment tool for cancer screening programs.
    Subramanian S; Ekwueme DU; Gardner JG; Trogdon J
    Am J Prev Med; 2009 Sep; 37(3):242-7. PubMed ID: 19666160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Economic approach to breast cancer screening in Belgium].
    Autier P; Grivegnée AR
    Rev Med Brux; 1995; 16(4):326-9. PubMed ID: 7481252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Do breast-feeding and other reproductive factors influence future risk of rheumatoid arthritis? Results from the Nurses' Health Study.
    Karlson EW; Mandl LA; Hankinson SE; Grodstein F
    Arthritis Rheum; 2004 Nov; 50(11):3458-67. PubMed ID: 15529351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of an expert system of composite risk factors in breast cancer screening.
    Tsouskas LI; Liaros A; Tzitzikas J; Pantelis P; Capizzello A; Papadopoulos LS
    Stud Health Technol Inform; 1997; 43 Pt B():859-63. PubMed ID: 10179790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Nationwide breast cancer screening fully accomplished; results from the implementation phase 1990-1997. National Evaluation Team for Breast Cancer Screening].
    Ned Tijdschr Geneeskd; 2000 Jun; 144(23):1124-9. PubMed ID: 10876708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessing prevention effectiveness using data to drive program decisions.
    Thacker SB; Koplan JP; Taylor WR; Hinman AR; Katz MF; Roper WL
    Public Health Rep; 1994; 109(2):187-94. PubMed ID: 8153269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost effectiveness of breast cancer screening with contrast-enhanced MRI in high-risk women.
    Taneja C; Edelsberg J; Weycker D; Guo A; Oster G; Weinreb J
    J Am Coll Radiol; 2009 Mar; 6(3):171-9. PubMed ID: 19248993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Benefit and projected cost-effectiveness of anastrozole versus tamoxifen as initial adjuvant therapy for patients with early-stage estrogen receptor-positive breast cancer.
    Hillner BE
    Cancer; 2004 Sep; 101(6):1311-22. PubMed ID: 15368322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early cancer detection programmes for women at high risk for breast and ovarian cancer: a proposal of practical guidelines.
    Beckmann MW; Schnürch HG; Bodden-Heidrich R; Mosny DS; Crombach G; Nitz U; Achnoula M; Bender HG
    Eur J Cancer Prev; 1996 Dec; 5(6):468-75. PubMed ID: 9061278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The 2003 Australian Breast Health Survey: survey design and preliminary results.
    Villanueva EV; Jones S; Nehill C; Favelle S; Steel D; Iverson D; Zorbas H
    BMC Public Health; 2008 Jan; 8():13. PubMed ID: 18194528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.